Search Results 491-500 of 2910 for site:slotspk17.com

  1. Parkinson's disease - Doctors and departments - Mayo Clinic

    There's no cure for this progressive movement disorder, but treatments can help your symptoms get better.

  2. A Study To Compare HF10 Therapy Combined With CMM To CMM Alone In The Treatment Of Non-Surgical Refractory Back Pain - Mayo Clinic

    The purpose of this study is to document the safety, clinical effectiveness and cost-effectiveness of high-frequency SCS at 10 kHz (HF10™ Therapy) delivered ...

  3. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial - Mayo Clinic

    A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute ...

  4. A Study To Evaluate The Effectiveness Of M7824 Monotherapy In Locally Advanced Or Metastatic Biliary Tract Cancer (Cholangiocarcinoma And Gallbladder Cancer) - Mayo Clinic

    The purpose of this study is to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant ...

  5. A Study Of LNK01002 In Patients With Primary (PMF) Or Secondary Myelofibrosis (PV-MF, ET-MF) Or Acute Myeloid Leukemia - Mayo Clinic

    The purpose of this study is to evaluate safety and tolerability of multi-kinase inhibitor LNK01002 in patients with primary myelofibrosis (MF), or MF due to ...

  6. A Study To Evaluate The Effectiveness And Safety Of Camidanlumab Tesirine (ADCT-301) In Patients With Relapsed Or Refractory Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory ...

  7. A Phase 2, Multicenter, Study Of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib In Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) And BDX004 Positive Label - Mayo Clinic

    A Phase 2, Multicenter, Study Of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib In Subjects Who Have Previously Untreated Metastatic, ...

  8. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  9. Panobinostat In Treating Patients With Relapsed Or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Panobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well panobinostat ...

  10. A Phase 1 Trial Of MK-4280 As Monotherapy And In Combination With Pembrolizumab With Or Without Chemotherapy Or Lenvatinib (E7080/MK 7902) In Subjects With Advanced Solid Tumors - Mayo Clinic

    This is a safety and pharmacokinetics study of MK-4280 as monotherapy and in combination with pembrolizumab (MK-3475) in adults with metastatic solid tumors for ...